Click on headlines below to download research

Inecalcitol advancing towards data
Hybrigenics | 31/01/2018

Hybrigenics’ main value driver is inecalcitol. A Phase II study in chronic myeloid leukaemia (CML) is on track to complete in H218. Interim analysis…

H117 results released, business on track
Hybrigenics | 15/11/2017

Hybrigenics has reported H117 financial results which have been restated to reflect the sale of the proteomics division. Hybrigenics continues to generate…